UBS Group Reiterates “Neutral” Rating for GlaxoSmithKline (LON:GSK)

UBS Group reiterated their neutral rating on shares of GlaxoSmithKline (LON:GSK) in a report issued on Thursday morning, ThisIsMoney.Co.Uk reports.

GSK has been the topic of a number of other research reports. Goldman Sachs Group set a $13.00 target price on shares of Ford Motor and gave the stock a buy rating in a research report on Thursday, June 13th. Morgan Stanley initiated coverage on shares of in a research report on Monday, June 17th. They set an equal weight rating and a GBX 215 ($2.81) target price on the stock. Credit Suisse Group initiated coverage on shares of Regeneron Pharmaceuticals in a research report on Monday, May 20th. They set a neutral rating and a $336.00 target price on the stock. Bryan, Garnier & Co dropped their target price on shares of GlaxoSmithKline from GBX 1,710 ($22.34) to GBX 1,660 ($21.69) and set a neutral rating on the stock in a research report on Thursday, May 2nd. Finally, Kepler Capital Markets boosted their target price on shares of GlaxoSmithKline from GBX 1,440 ($18.82) to GBX 1,540 ($20.12) and gave the stock a hold rating in a research report on Tuesday, June 11th. Two equities research analysts have rated the stock with a sell rating, twelve have given a hold rating and five have issued a buy rating to the company’s stock. The stock currently has an average rating of Hold and a consensus price target of GBX 1,532.32 ($20.02).

LON:GSK opened at GBX 1,623.80 ($21.22) on Thursday. GlaxoSmithKline has a 12 month low of GBX 1,408.80 ($18.41) and a 12 month high of GBX 1,651 ($21.57). The company has a market capitalization of $81.00 billion and a price-to-earnings ratio of 20.69. The company has a debt-to-equity ratio of 942.07, a quick ratio of 0.45 and a current ratio of 0.72. The company has a 50 day moving average price of GBX 1,584.74.

The firm also recently declared a dividend, which was paid on Thursday, July 11th. Shareholders of record on Thursday, May 16th were paid a dividend of GBX 19 ($0.25) per share. The ex-dividend date was Thursday, May 16th. This represents a yield of 1.22%. GlaxoSmithKline’s dividend payout ratio is currently 0.97%.

In other GlaxoSmithKline news, insider Manvinder Singh Banga purchased 458 shares of the firm’s stock in a transaction on Wednesday, May 1st. The shares were purchased at an average price of GBX 1,568 ($20.49) per share, for a total transaction of £7,181.44 ($9,383.82). Insiders have acquired 482 shares of company stock worth $755,935 in the last quarter.

GlaxoSmithKline Company Profile

GlaxoSmithKline plc engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare.

Featured Article: What is the Quick Ratio?

Analyst Recommendations for GlaxoSmithKline (LON:GSK)

Receive News & Ratings for GlaxoSmithKline Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GlaxoSmithKline and related companies with MarketBeat.com's FREE daily email newsletter.